Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 1977 Dec;36(6):804–809. doi: 10.1038/bjc.1977.265

Malignant melanoma and oral contraceptive use among women in California.

V Beral, S Ramcharan, R Faris
PMCID: PMC2025573  PMID: 597478

Abstract

Women who had used oral contraceptives, particularly long-term users, were found to have higher rates of malignant melanoma and of a past history of skin cancer than those who had never used oral contraceptives. This excess was confined to lesions of the lower limb. The association between oral contraceptive use and melanoma was noted in 3 separate sets of data, although it was statistically significant only in one. The possibility that this relationship is indirect because, for example, oral contraceptive users are more likely than never-users to be exposed to sunlight and thus to develop malignant melanoma, cannot be excluded.

Full text

PDF
804

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. COOK H. H., GAMBLE C. J., SATTERTHWAITE A. P. Oral contraception by norethynodrel. A 3 year field study. Am J Obstet Gynecol. 1961 Aug;82:437–445. [PubMed] [Google Scholar]
  2. Carruthers R. Chloasma and oral contraceptives. Med J Aust. 1966 Jul 2;2(1):17–20. [PubMed] [Google Scholar]
  3. Carruthers R. Chloasma and the "Pill". Br Med J. 1967 Jul 29;3(5560):307–307. doi: 10.1136/bmj.3.5560.307-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Ellerbroek W. C. Oral contraceptives and malignant melanoma. JAMA. 1968 Oct 14;206(3):649–650. doi: 10.1001/jama.1968.03150030105038. [DOI] [PubMed] [Google Scholar]
  5. Gellin G. A., Kopf A. W., Garfinkel L. Malignant melanoma. A controlled study of possibly associated factors. Arch Dermatol. 1969 Jan;99(1):43–48. doi: 10.1001/archderm.99.1.43. [DOI] [PubMed] [Google Scholar]
  6. Hersey P., Morgan G., Stone D. E., McCarthy W. H., Milton G. W. Previous pregnancy as a protective factor against death from melanoma. Lancet. 1977 Feb 26;1(8009):451–452. doi: 10.1016/s0140-6736(77)91943-2. [DOI] [PubMed] [Google Scholar]
  7. Jelinek J. E. Cutaneous side effects of oral contraceptives. Arch Dermatol. 1970 Feb;101(2):181–186. [PubMed] [Google Scholar]
  8. Koide S. S., Lyle K. C. Unusal signs and symptoms associated with oral contraceptive medication. J Reprod Med. 1975 Dec;15(6):214–224. [PubMed] [Google Scholar]
  9. LANCASTER H. O., NELSON J. Sunlight as a cause of melanoma; a clinical survey. Med J Aust. 1957 Apr 6;44(14):452–456. [PubMed] [Google Scholar]
  10. Lee J. A., Yongchaiyudha S. Incidence of and mortality from malignant melanoma by anatomical site. J Natl Cancer Inst. 1971 Jul;47(1):253–263. [PubMed] [Google Scholar]
  11. Magnus K. Incidence of malignant melanoma of the skin in Norway, 1955-1970. Variations in time and space and solar radiation. Cancer. 1973 Nov;32(5):1275–1286. doi: 10.1002/1097-0142(197311)32:5<1275::aid-cncr2820320537>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
  12. SNELL R. S., BISCHITZ P. G. The effect of large doses of estrogen and estrogen and progesterone on melanin pigmentation. J Invest Dermatol. 1960 Aug;35:73–82. doi: 10.1038/jid.1960.87. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES